NEUGUIDE
Device
FEMSelect Inc.
Total Payments
$203,580
Transactions
96
Doctors
11
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $36,666 | 29 | 4 |
| 2020 | $104,843 | 45 | 8 |
| 2019 | $55,072 | 20 | 4 |
| 2018 | $7,000 | 2 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $105,074 | 52 | 51.6% |
| Unspecified | $84,201 | 34 | 41.4% |
| Travel and Lodging | $11,221 | 7 | 5.5% |
| Food and Beverage | $3,084 | 3 | 1.5% |
Payments by Type
General
$119,379
62 transactions
Research
$84,201
34 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| The NeuGuide System for Vaginal Colpopexy in the Treatment of Uterine Prolapse Post-Market Surveillance Clinical Study | FEMSelect Inc. | $84,201 | 1 |
Top Doctors Receiving Payments for NEUGUIDE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Urogynecology and Reconstructive Pelvic Surgery | Allentown, PA | $91,858 | 41 |
| Unknown | — | Fairfax, VA | $82,976 | 31 |
| , MD | Obstetrics & Gynecology | Falls Church, VA | $12,974 | 4 |
| , MD | Obstetrics & Gynecology | Idaho Falls, ID | $6,000 | 2 |
| , M.D | Obstetrics & Gynecology | Bethlehem, PA | $2,482 | 5 |
| , M.D | Obstetrics & Gynecology | Dallas, TX | $2,000 | 4 |
| , MD | Obstetrics & Gynecology | Newtown, PA | $2,000 | 1 |
| , MD | Urogynecology and Reconstructive Pelvic Surgery | Cambridge, MA | $1,225 | 3 |
| , MD | Urogynecology and Reconstructive Pelvic Surgery | New York, NY | $1,000 | 2 |
| , MD | Urogynecology and Reconstructive Pelvic Surgery | Phoenix, AZ | $500.00 | 1 |
| , M.D | Obstetrics & Gynecology | Covington, WA | $434.39 | 1 |
| , M.D | Urology | Elgin, SC | $130.53 | 1 |
Ad
Manufacturing Companies
- FEMSelect Inc. $203,580
Product Information
- Type Device
- Total Payments $203,580
- Total Doctors 11
- Transactions 96
About NEUGUIDE
NEUGUIDE is a device associated with $203,580 in payments to 11 healthcare providers, recorded across 96 transactions in the CMS Open Payments database. The primary manufacturer is FEMSelect Inc..
Payment data is available from 2018 to 2021. In 2021, $36,666 was paid across 29 transactions to 4 doctors.
The most common payment nature for NEUGUIDE is "Consulting Fee" ($105,074, 51.6% of total).
NEUGUIDE is associated with 1 research study, including "The NeuGuide System for Vaginal Colpopexy in the Treatment of Uterine Prolapse Post-Market Surveillance Clinical Study" ($84,201).